Background & Aims Barrett's esophagus (BE) is the precursor to esophageal
adenocarcinoma (EAC). Endoscopic eradication therapy (EET) can be effective in …

Endoscopic eradication therapy (EET) can be effective in eradicating BE and related
neoplasia, and has greater risk of harms and resource use than surveillance endoscopy …

Endoscopic eradication therapy (EET) has revolutionized the management of patients with
Barrett's esophagus (BE)–related dysplasia and early esophageal adenocarcinoma (EAC) …

Background Complete endoscopic mucosal resection [EMR] is an established approach for
complete eradication of Barrett's esophagus [BE] related neoplasia: high-grade dysplasia …

Barrett esophagus (BE) is the only identifiable premalignant condition for esophageal
adenocarcinoma (EAC), a cancer associated with a poor 5-year survival rate. The stepwise …

Comment. This multicenter, prospective European study further solidifies the effectiveness of
multimodality endoscopic eradication therapy in the management of patients with BE-related …

Barrett's esophagus (BE) is the only identifiable premalignant condition for esophageal
adenocarcinoma (EAC), a cancer that has increased nearly six-fold over the past three …

Advances in endoscopic eradication therapy for Barrett's Esophagus-associated neoplasia
have resulted in a significant paradigm shift in the diagnosis and management of this …

EET is now standard of care and endorsed by societal guidelines for the treatment of
Barrett's oesophagus related neoplasia. Future studies should focus on risk stratification …

Introduction Endoscopic eradication therapy (EET) is the preferred treatment for Barrett's
esophagus (BE)-related neoplasia patients. However, the impact of EET on critical …